Search results
Results from the WOW.Com Content Network
Meconium aspiration syndrome (MAS), also known as neonatal aspiration of meconium, is a medical condition affecting newborn infants. It describes the spectrum of disorders and pathophysiology of newborns born in meconium-stained amniotic fluid (MSAF) and have meconium within their lungs.
The disease ranges from mild to severe, and occurs in the second or subsequent pregnancies of Rh-D negative women when the biologic father is Rh-D positive. Due to several advances in modern medicine, HDFN due to anti-D is preventable by treating the mother during pregnancy and soon after delivery with an injection of anti-Rh o (D) immune ...
The European Consensus Guidelines on the Management of Respiratory Distress Syndrome highlight new possibilities for early detection, and therefore treatment of IRDS. [8] The guidelines mention an easy to use rapid point-of-care predictive test that is now available [9] and how lung ultrasound, with appropriate training, expertise and equipment ...
Within the first hour of life, blood glucose will typically reach its lowest point and then stabilize within 2 to 4 hours, hence breastfeeding is promoted immediately. In cases where feeding is delayed, the neonate can use lactate, free-fatty acids, and ketone bodies. Manifestations: Normal blood glucose levels range from 40 to 50 mg/dl. [1]
It is the most common cause of respiratory distress in term neonates. [2] [3] It consists of a period of tachypnea (rapid breathing, higher than the normal range of 30–60 times per minute). Usually, this condition resolves over 24–72 hours. Treatment is supportive and may include supplemental oxygen and antibiotics.
[4] [12] [14] Appropriate IAP in GBS colonized women should start as soon as possible once labour starts or the waters have broken. When the first dose is given at least 4 hours before delivery, the risk of neonatal infection is very small; moreover, when given between 2–4 hours before delivery the risk is only partially reduced. [36] [37] [38]
Phototherapy is the main treatment of neonatal jaundice. Babies with neonatal jaundice may be treated with colored light called phototherapy, which works by changing trans-bilirubin into the water-soluble cis-bilirubin isomer. [26] [27] [28]: 2533
Newborn Screening Tests - Transfusion with donor blood during pregnancy or shortly after birth can affect the results of the Newborn Screening Tests. It is recommended to wait and retest 10–12 months after the last transfusion. In some cases, DNA testing from saliva can be used to rule out certain conditions. [citation needed]